【Abstract】ObjectiveTo investigate the role of apoptosis-related gene survivin, caspase-3 and cyclin-B1 in gastric carcinoma by detecting the expressions of survivin, caspase-3 and cyclin-B1 in gastric carcinoma.
Methods The expressions of survivin mRNA, caspase-3 mRNA and cyclin-B1 mRNA were determined by reverse transcription-polymerase chain reaction (RT-PCR) method in 30 gastric carcinoma specimens and 10 normal gastric tissue specimens.
ResultsThe positive expression rate of survivin mRNA in 30 gastric carcinoma specimens was 66.7%(20/30). While 10 normal gastric tissue specimens did not express survivin mRNA. Although all of 30 gastric carcinoma tissues and 10 normal gastric tissues expressed caspase-3 mRNA and cyclin-B1 mRNA, the expressions of caspase-3 and cyclin-B1 in 20 survivin-positive gastric carcinoma tissues were significantly lower than those of 10 survivin-negative gastric carcinoma tissues (P<0.01) and 10 normal gastric tissues (P<0.01). The expressions of caspase-3 mRNA and cyclinB1 mRNA in 10 survivin-negative gastric carcinoma tissues were significantly lower than those of 10 normal gastric tissues (P<0.01). And in gastric carcinoma tissues the expression of survivin mRNA was negatively related with that of caspase-3 mRNA (r=-0.923,P<0.01) and cyclin-B1 mRNA (r=-0.886,P<0.01), the expression of caspase-3 mRNA was positively related with that of cyclin-B1 mRNA (r=0.892, P<0.01).
Conclusionsurvivin enhances gastric tumorigenesis, caspase-3 and cyclin-B1 inhibit gastric tumorigenesis.
Citation:
WEN Yayuan,LIU Baohua,HONG Shenglong,FU Tao.. Role of Apoptosis-Related Gene survivin, caspase-3 and cyclin-B1 in Gastric Carcinoma Tumorigenesis. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2006, 13(1): 34-37. doi:
Copy
Copyright © the editorial department of CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY of West China Medical Publisher. All rights reserved
1. |
Ambrosini G, Adida C, Sirugo G, et al. Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting [J]. J Biol Chem, 1998; 273(18)∶11177.
|
2. |
Bao R, Connolly DC, Murphy M, et al. Activation of cancerspecific gene expression by the survivin promoter [J]. J Natl Cancer Inst, 2002; 94(7)∶522.
|
3. |
Raff M. Cell suicide for beginners [J]. Nature, 1998; 396(6707)∶119.
|
4. |
Hu S, Snipas SJ, Vincenz C, et al. Caspase14 is a novel developmentally regulated protease [J]. J Biol Chem, 1998; 273(45)∶29648.
|
5. |
Altieri DC. The molecular basis and potential role of survivin in cancer diagnosis and therapy [J]. Trends Mol Med, 2001; 7(12)∶542.
|
6. |
Reed JC. Dysregulation of apoptosis in cancer [J]. J Clin Oncol, 1999; 17(9)∶2941.
|
7. |
O’Connor DS, Grossman D, Plescia J, et al. Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin [J]. Proc Natl Acad Sci USA, 2000; 97(24)∶13103.
|
8. |
Suzuki A, Ito T, Kawano H, et al. Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fasmediated cell death [J]. Oncogene, 2000; 19(10)∶1346.
|
9. |
Hoeijmakers JH. Genome maintenance mechanisms for preventing cancer [J]. Nature, 2001; 411(6835)∶366.
|
10. |
Dynlacht BD. Regulation of transcription by proteins that control the cell cycle [J]. Nature, 1997; 389(6647)∶149.
|
11. |
Muschel RJ, Zhang HB, McKenna WG. Differential effect of ionizing radiation on the expression of cyclin A and cyclin B in HeLa cells [J]. Cancer Res, 1993; 53(5)∶1128.
|
12. |
Sayed M, Pelech S, Wong C, et al. Protein kinase CK2 is involved in G2 arrest and apoptosis following spindle damage in epithelial cells [J]. Oncogene, 2001; 20(48)∶6994.
|
13. |
Hardcastle IR, Arris CE, Bentley J, et al. N2substituted O6cyclohexylmethylguanine derivatives: potent inhibitors of cyclindependent kinases 1 and 2 [J]. J Med Chem, 2004; 47(15)∶3710.
|
14. |
Murakami MS, Moody SA, Daar IO, et al. Morphogenesis during Xenopus gastrulation requires Wee1mediated inhibition of cell proliferation [J]. Development, 2004; 131(3)∶571.
|
- 1. Ambrosini G, Adida C, Sirugo G, et al. Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting [J]. J Biol Chem, 1998; 273(18)∶11177.
- 2. Bao R, Connolly DC, Murphy M, et al. Activation of cancerspecific gene expression by the survivin promoter [J]. J Natl Cancer Inst, 2002; 94(7)∶522.
- 3. Raff M. Cell suicide for beginners [J]. Nature, 1998; 396(6707)∶119.
- 4. Hu S, Snipas SJ, Vincenz C, et al. Caspase14 is a novel developmentally regulated protease [J]. J Biol Chem, 1998; 273(45)∶29648.
- 5. Altieri DC. The molecular basis and potential role of survivin in cancer diagnosis and therapy [J]. Trends Mol Med, 2001; 7(12)∶542.
- 6. Reed JC. Dysregulation of apoptosis in cancer [J]. J Clin Oncol, 1999; 17(9)∶2941.
- 7. O’Connor DS, Grossman D, Plescia J, et al. Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin [J]. Proc Natl Acad Sci USA, 2000; 97(24)∶13103.
- 8. Suzuki A, Ito T, Kawano H, et al. Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fasmediated cell death [J]. Oncogene, 2000; 19(10)∶1346.
- 9. Hoeijmakers JH. Genome maintenance mechanisms for preventing cancer [J]. Nature, 2001; 411(6835)∶366.
- 10. Dynlacht BD. Regulation of transcription by proteins that control the cell cycle [J]. Nature, 1997; 389(6647)∶149.
- 11. Muschel RJ, Zhang HB, McKenna WG. Differential effect of ionizing radiation on the expression of cyclin A and cyclin B in HeLa cells [J]. Cancer Res, 1993; 53(5)∶1128.
- 12. Sayed M, Pelech S, Wong C, et al. Protein kinase CK2 is involved in G2 arrest and apoptosis following spindle damage in epithelial cells [J]. Oncogene, 2001; 20(48)∶6994.
- 13. Hardcastle IR, Arris CE, Bentley J, et al. N2substituted O6cyclohexylmethylguanine derivatives: potent inhibitors of cyclindependent kinases 1 and 2 [J]. J Med Chem, 2004; 47(15)∶3710.
- 14. Murakami MS, Moody SA, Daar IO, et al. Morphogenesis during Xenopus gastrulation requires Wee1mediated inhibition of cell proliferation [J]. Development, 2004; 131(3)∶571.